Bartter vrs Gitelman Syndrome Flashcards
BARTTER VERSUS GITELMAN SYNDROMES
Think furosemide (Bartter) versus thiazides (Gitelman). As these syndromes are equivalent to taking diuretics, they can induce salt loss and relative volume depletion, hence “compensatory” hyperrenin hyperaldosteronism without associated hypertension.
BARTTER VERSUS GITELMAN SYNDROMES
As mutations of Bartter syndromes can lead to greater salt-wasting compared with Gitelman, hyperrenin and hyperaldosteronism are more marked in the former. Increased vasodilating prostaglandin E2 production is also thought to play a role in maintaining normotension in Bartter syndromes.
BARTTER VERSUS GITELMAN SYNDROMES
Similar to taking diuretics, both Bartter and Gitelman syndromes are associated with hypokalemia and metabolic alkalosis.
BARTTER VERSUS GITELMAN SYNDROMES
Mutations in Bartter Syndromes
Neonatal Bartter syndromes: types I (NKCC2) and II (ROMK—renal outer medullary K+ channel)
BARTTER VERSUS GITELMAN SYNDROMES
Mutations in Bartter Syndromes
Classic Bartter syndrome: type III (ClC-Kb)
BARTTER VERSUS GITELMAN SYNDROMES
Mutations in Bartter Syndromes
Bartter syndrome and sensorineural deafness (BSND): type IV Bartter (β-subunit of ClC-Ka and ClC-Kb); ClC-Ka is present in inner ear.
BARTTER VERSUS GITELMAN SYNDROMES
Mutations in Bartter Syndromes
Calcium-sensing receptor (CaSR) gain-of-function mutation (inhibits ROMK): type V Bartter, associated with autosomal dominant hypocalcemia. Activation of CaSR inhibits ROMK activity
BARTTER VERSUS GITELMAN SYNDROMES
Mutations in Bartter Syndromes
BARTTER VERSUS GITELMAN SYNDROMES
Mutations in Bartter Syndromes
NOTE
K+ recycling back into the lumen via ROMK creates a positively charged lumen which facilitates divalent cation (Ca2+, Mg2+) reabsorption paracellularly. This process is facilitated by tight junction proteins claudin 16 and 19.
BARTTER VERSUS GITELMAN SYNDROMES
Mutations in Bartter Syndromes
NOTE
Any transporter defect leading to suboptimal K+ recycling (e.g. loss of function mutation of ROMK or gain of function mutation of CaSR) or mutation of claudin 16/19 induces Ca2+ and Mg2+ wasting
Mutation in Gitelman Syndrome Mutation of NCC a.k.a. TSC
Clinical Manifestations of Bartter and Gitelman Syndrome
NOTE
CLC-Kb is present in both loop of henle and distal convoluted tubule. This may explain minimal or absence of nephrocalcinosis in classic Bartter and BSND, respectively.
NOTE
Hypomagnesemia is a prominent feature with Gitelman, but not typical with bartter syndromes. Reasons are not clear but suggested here:
There are apoptotic and/or histologic changes in DCT in patients with Gitelman that could affect DCT Mg2+ reabsorption, but not in patients with Bartter syndrome. These changes are thought to occur later than other electrolyte changes, hence the absence of hypomagnesemia observed in early disease.
Compensatory DCT Mg2+ reabsorption with loop Mg2+ wasting
Management of Bartter and Gitelman Syndromes
Potassium and magnesium supplement as needed
Consider renin angiotensin aldosterone inibitors